Roland Landman

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Dominique Roulot, Ségolène Brichler, Richard Layese et al. · Journal of Hepatology · 2020 · 145 citations · Full text

Hepatitis D, Viral Persistence, Hepatology +10

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

José Ramón Arribas, Pierre‐Marie Girard, Roland Landman et al. · The Lancet Infectious Diseases · 2015 · 142 citations · Full text

Hiv/aids Counselling, Human Retrovirus, Antiviral Drug Development +9

PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTS

Pierre‐Marie Girard, C. Gaudebout, Philippe Lottin et al. · The Lancet · 1989 · 94 citations

Antibiotics, Medicine, Respiratory Infection +4

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

Roland Landman, Ricarda Schiemann, Safiatou Thiam et al. · AIDS · 2003 · 90 citations

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 78 citations